Peter Schlattmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Peter Schlattmann has a total of 272 co-authors. Here are the top co-authors by number of shared publications:
- Orlando Guntinas-Lichius
Department of Otorhinolaryngology, Head and Neck Surgery, Jena University Hospital, Jena, Germany
6 shared publications - Paul Christian Schulze
University Hospital Jena, Friedrich-Schiller-University, Germany (P.C.S.).
5 shared publications - Michael Kiehntopf
Institute of Clinical Chemistry and Laboratory Diagnostics, Jena University Hospital, Jena, Germany
4 shared publications - Carolin Fleischmann-Struzek
Institute of Infectious Diseases and Infection Control, Friedrich Schiller University Jena, Jena University Hospital, Jena, Germany
3 shared publications - Christine Dawczynski
Junior Research Group Nutritional Concepts, Institute of Nutritional Sciences, Friedrich Schiller University Jena, Germany
3 shared publications - Marcus Franz
Department of Internal Medicine I, University Hospital Jena, Jena, Germany
3 shared publications
Latest Publications
- 29 September 2026
- Published by SAGE Publications in Statistical Methods in Medical Research
Generalizing the two sources capture–recapture estimator for covariate information
Dual system estimation is a statistical tool used to estimate the hidden population where each of the two sources covers part of the population. In estimation, the widely used Lincoln–Petersen and Chapman estimators are used under the assumption of two-source independence. However, this situation is often unrealistic, and the traditional estimators might have a large bias, especially if the two sources experience a large dependence. To improve the methodology, covariate information is used for stratification. We formulate the strata-adjusted Chapman estimator for estimating the population size. Furthermore, the log-linear modeling approach is adopted to cope with covariate information. Two semi-parametric (imputed) bootstrap methods using the log-linear model with and without incorporating the model selection procedure are proposed to quantify the uncertainty surrounding the estimates of the unknown population size. Across all designs, methods that exploit covariate information—either via stratification or within the log-linear modeling framework—consistently reduce bias and mean squared error relative to unadjusted estimators that ignore heterogeneity. For interval estimation, the imputed bootstrap that incorporates model selection in each replicate achieves coverage close to the nominal level across heterogeneous and sparse regimes, typically outperforming both the fixed-model bootstrap and normal-theory intervals for the strata-adjusted Chapman. We illustrate these approaches in an application to estimate the hidden number of suicides in Cambodia and heroin users in Thailand.
- 29 September 2026
- Published by SAGE Publications in Statistical Methods in Medical Research
Generalizing the two sources capture–recapture estimator for covariate information
Dual system estimation is a statistical tool used to estimate the hidden population where each of the two sources covers part of the population. In estimation, the widely used Lincoln–Petersen and Chapman estimators are used under the assumption of two-source independence. However, this situation is often unrealistic, and the traditional estimators might have a large bias, especially if the two sources experience a large dependence. To improve the methodology, covariate information is used for stratification. We formulate the strata-adjusted Chapman estimator for estimating the population size. Furthermore, the log-linear modeling approach is adopted to cope with covariate information. Two semi-parametric (imputed) bootstrap methods using the log-linear model with and without incorporating the model selection procedure are proposed to quantify the uncertainty surrounding the estimates of the unknown population size. Across all designs, methods that exploit covariate information—either via stratification or within the log-linear modeling framework—consistently reduce bias and mean squared error relative to unadjusted estimators that ignore heterogeneity. For interval estimation, the imputed bootstrap that incorporates model selection in each replicate achieves coverage close to the nominal level across heterogeneous and sparse regimes, typically outperforming both the fixed-model bootstrap and normal-theory intervals for the strata-adjusted Chapman. We illustrate these approaches in an application to estimate the hidden number of suicides in Cambodia and heroin users in Thailand.
- Open Access
The Impact of Comorbidity on Severe Procedure-Coded Inpatient Events in Head and Neck Cancer and Thyroid Cancer Hospitalizations in Germany: A Nationwide DRG Analysis, 2005–2021
Background: Comorbidity is an important determinant of treatment selection and in-hospital complications in patients with head and neck cancer (HNC) and thyroid cancer (TC), yet population-based evidence on this relationship remains limited. Methods: We analyzed nationwide Diagnosis-Related Groups (DRG) data from 1,552,028 inpatient HNC and TC treatments of patients aged ≥30 years in Germany between 2005 and 2021. The aim was to characterize the association of comorbidity and severe treatment-related procedure-coded inpatient events (IEs) with gender, age, tumor subsite, and treatment type. Results: The largest proportion of treatments occurred in patients aged 60–69 years (33.5%). The most frequent tumor subsites were the oropharynx, thyroid gland, oral cavity, larynx, and hypopharynx, with 35.52, 33.84, 33.60, 26.12, and 15.76 treatments per 100,000 population per year, respectively. Overall, 38% of cases had a Charlson Comorbidity Index (CCI) ≥ 1, with the highest mean CCI observed for C14 (other sites of the lip, oral cavity and pharynx) and C12 (piriform sinus). IEs requiring additional in-hospital treatment occurred in 19.3% of cases. After adjustment for age, tumor location, and treatment type, men had a lower risk of IEs than women (OR 0.929; CI 0.919–0.939; p < 0.001). Increasing comorbidity was associated with a higher IE risk, reaching a plateau at CCI ≥ 4 (OR 2.135; CI 2.029–2.246; p < 0.001). IE risk was high during chemotherapy/immunotherapy (OR 29.527; CI 28.897–30.170; p < 0.001), followed by surgery (OR 3.465; CI 3.433–3.498; p < 0.001), whereas radiotherapy showed the lowest risk (OR 1.339; CI 1.313–1.366; p < 0.001). Conclusions: These findings highlight substantial heterogeneity in comorbidity and IE risk among patients with HNC or TC.
Open AccessThe Impact of Comorbidity on Severe Procedure-Coded Inpatient Events in Head and Neck Cancer and Thyroid Cancer Hospitalizations in Germany: A Nationwide DRG Analysis, 2005–2021
Background: Comorbidity is an important determinant of treatment selection and in-hospital complications in patients with head and neck cancer (HNC) and thyroid cancer (TC), yet population-based evidence on this relationship remains limited. Methods: We analyzed nationwide Diagnosis-Related Groups (DRG) data from 1,552,028 inpatient HNC and TC treatments of patients aged ≥30 years in Germany between 2005 and 2021. The aim was to characterize the association of comorbidity and severe treatment-related procedure-coded inpatient events (IEs) with gender, age, tumor subsite, and treatment type. Results: The largest proportion of treatments occurred in patients aged 60–69 years (33.5%). The most frequent tumor subsites were the oropharynx, thyroid gland, oral cavity, larynx, and hypopharynx, with 35.52, 33.84, 33.60, 26.12, and 15.76 treatments per 100,000 population per year, respectively. Overall, 38% of cases had a Charlson Comorbidity Index (CCI) ≥ 1, with the highest mean CCI observed for C14 (other sites of the lip, oral cavity and pharynx) and C12 (piriform sinus). IEs requiring additional in-hospital treatment occurred in 19.3% of cases. After adjustment for age, tumor location, and treatment type, men had a lower risk of IEs than women (OR 0.929; CI 0.919–0.939; p < 0.001). Increasing comorbidity was associated with a higher IE risk, reaching a plateau at CCI ≥ 4 (OR 2.135; CI 2.029–2.246; p < 0.001). IE risk was high during chemotherapy/immunotherapy (OR 29.527; CI 28.897–30.170; p < 0.001), followed by surgery (OR 3.465; CI 3.433–3.498; p < 0.001), whereas radiotherapy showed the lowest risk (OR 1.339; CI 1.313–1.366; p < 0.001). Conclusions: These findings highlight substantial heterogeneity in comorbidity and IE risk among patients with HNC or TC.
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Effects of a Multimodal Awareness Campaign to Improve Vaccine Prevention and Early Detection of Sepsis among Patient Groups at Risk – Results of the SepWiss Controlled Intervention Study
Background: Sepsis is a leading cause of mortality worldwide, yet sepsis knowledge remains poor and preventive strategies underused. We assessed the impact of the awareness campaign “SepsisWissen” (SepWiss) on vaccination coverage among German adult at-risk groups.Methods: Controlled before-after study (intervention vs. control regions). Primary outcome was vaccination coverage for seasonal Influenza, pneumococcal, meningococcal vaccines, and incidence for Haemophilus influenzae type b (Hib) vaccines among at-risk groups. Intervention effects were estimated using difference-in-differences generalized linear models with negative binomial distribution. Secondary outcomes were sepsis knowledge, emergency recognition, vaccination attitudes, assessed via longitudinal surveys and analyzed using multi-group structural equation models adjusted for baseline covariates.Findings: There was no evidence of a consistent intervention effect on vaccination uptake. Small positive effects were observed for influenza (age18–59; ratio of rate ratios (RRR) 1·031, 95%CI 1·02–1·04) and pneumococcal vaccination (age<18; RRR 1·15, 95%CI 1·09–1·22); small negative effects for pneumococcal (age60–69; RRR 0·90 95%CI 0·865–0·937) and meningococcal vaccination (age18–59; RRR 0·915 95%CI 0·857–0·977).In the post-campaign survey (n=260), self-reported campaign contact was higher in the intervention region (20·0% vs. 1·5%). We found no significant regional difference in sepsis knowledge after the campaign. In a planned subgroup analysis, participants reporting campaign contact showed higher sepsis knowledge (average treatment effect (ATE) = 3·02, p<0·01), and more positive attitudes toward influenza (ATE=0·16, p=0·04) and COVID-19 vaccination (ATE=0·38, p<0·01).Interpretation: Improvements among exposed individuals suggest that evidence-based sepsis communication can be effective when received. Sustainable impact liekly requires broader, sustained public messaging linked to actionable prevention pathways, for example through primary-care reminders and targeted insurer communication.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEffects of a Multimodal Awareness Campaign to Improve Vaccine Prevention and Early Detection of Sepsis among Patient Groups at Risk – Results of the SepWiss Controlled Intervention Study
Background: Sepsis is a leading cause of mortality worldwide, yet sepsis knowledge remains poor and preventive strategies underused. We assessed the impact of the awareness campaign “SepsisWissen” (SepWiss) on vaccination coverage among German adult at-risk groups.Methods: Controlled before-after study (intervention vs. control regions). Primary outcome was vaccination coverage for seasonal Influenza, pneumococcal, meningococcal vaccines, and incidence for Haemophilus influenzae type b (Hib) vaccines among at-risk groups. Intervention effects were estimated using difference-in-differences generalized linear models with negative binomial distribution. Secondary outcomes were sepsis knowledge, emergency recognition, vaccination attitudes, assessed via longitudinal surveys and analyzed using multi-group structural equation models adjusted for baseline covariates.Findings: There was no evidence of a consistent intervention effect on vaccination uptake. Small positive effects were observed for influenza (age18–59; ratio of rate ratios (RRR) 1·031, 95%CI 1·02–1·04) and pneumococcal vaccination (age<18; RRR 1·15, 95%CI 1·09–1·22); small negative effects for pneumococcal (age60–69; RRR 0·90 95%CI 0·865–0·937) and meningococcal vaccination (age18–59; RRR 0·915 95%CI 0·857–0·977).In the post-campaign survey (n=260), self-reported campaign contact was higher in the intervention region (20·0% vs. 1·5%). We found no significant regional difference in sepsis knowledge after the campaign. In a planned subgroup analysis, participants reporting campaign contact showed higher sepsis knowledge (average treatment effect (ATE) = 3·02, p<0·01), and more positive attitudes toward influenza (ATE=0·16, p=0·04) and COVID-19 vaccination (ATE=0·38, p<0·01).Interpretation: Improvements among exposed individuals suggest that evidence-based sepsis communication can be effective when received. Sustainable impact liekly requires broader, sustained public messaging linked to actionable prevention pathways, for example through primary-care reminders and targeted insurer communication.
- 20 July 2026
- Published by Wolters Kluwer Health in Biopsychosocial Science and Medicine
- Vol. 88 (8) , 699-702
Effect of Short-Term Psychological Intervention on Depression Dynamics in Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation
Objective: Because depression has been identified as a relevant comorbidity in cardiovascular patients, we aimed to assess the impact of a brief expectation-focused psychological intervention on depression dynamics in aortic stenosis patients undergoing transcatheter aortic valve implantation (TAVI). Methods: From 82 TAVI patients showing a Hospital Anxiety and Depression Scale (HADS-D) score ≥8 points for depression, 74 patients underwent 1:1 randomization, with 38 assigned to the control (CON; treatment as usual) and 36 to the intervention (INT; psychological short-term intervention) group. The psychological intervention consisted of 2 individual sessions before and 2 booster sessions after TAVI. Per protocol, the HADS-D score for depression at 6 months was defined as the primary outcome and compared with baseline between the CON and the INT group by using analysis of covariance (ANCOVA). Results: Regarding the primary outcome measure, there was a mean HADS-D depression score of 10.76 (SD: 2.77) at baseline and 9.44 (SD: 4.56) at 6 months after TAVI in the CON group and of 9.86 (SD: 2.0) at baseline and 7.5 (SD: 3.15) at 6 months after TAVI in the INT group. ANCOVA did not show a significant effect of the psychological short-term interventions versus control (estimate=−1.67; 95% CI=−3.64 to −0.29) on depression dynamics 6 months after TAVI, adjusted for baseline HADS-D. Conclusions: An effect of a psychological intervention on depression dynamics could not be shown. However, there was an improvement in depression at 6 months after TAVI, which is probably due to a decline in heart failure symptoms.
- 20 July 2026
- Published by Wolters Kluwer Health in Biopsychosocial Science and Medicine
- Vol. 88 (8) , 699-702
Effect of Short-Term Psychological Intervention on Depression Dynamics in Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation
Objective: Because depression has been identified as a relevant comorbidity in cardiovascular patients, we aimed to assess the impact of a brief expectation-focused psychological intervention on depression dynamics in aortic stenosis patients undergoing transcatheter aortic valve implantation (TAVI). Methods: From 82 TAVI patients showing a Hospital Anxiety and Depression Scale (HADS-D) score ≥8 points for depression, 74 patients underwent 1:1 randomization, with 38 assigned to the control (CON; treatment as usual) and 36 to the intervention (INT; psychological short-term intervention) group. The psychological intervention consisted of 2 individual sessions before and 2 booster sessions after TAVI. Per protocol, the HADS-D score for depression at 6 months was defined as the primary outcome and compared with baseline between the CON and the INT group by using analysis of covariance (ANCOVA). Results: Regarding the primary outcome measure, there was a mean HADS-D depression score of 10.76 (SD: 2.77) at baseline and 9.44 (SD: 4.56) at 6 months after TAVI in the CON group and of 9.86 (SD: 2.0) at baseline and 7.5 (SD: 3.15) at 6 months after TAVI in the INT group. ANCOVA did not show a significant effect of the psychological short-term interventions versus control (estimate=−1.67; 95% CI=−3.64 to −0.29) on depression dynamics 6 months after TAVI, adjusted for baseline HADS-D. Conclusions: An effect of a psychological intervention on depression dynamics could not be shown. However, there was an improvement in depression at 6 months after TAVI, which is probably due to a decline in heart failure symptoms.
- Open Access
- 17 July 2026
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 154 (5) , 376-383
Patients With Atypical Symptoms of Depression Respond Better to Lithium Augmentation Than Patients Without Atypical Symptoms
Introduction: Understanding the differences in treatment response between subtypes of major depressive disorder (MDD) may help to prevent lengthy trial‐and‐error processes by identifying effective treatment options. The aim of the study was to investigate the impact of atypical features of MDD (MDD‐A) on the response to lithium augmentation (LA). Methods: In a multicenter prospective cohort study, response to LA was compared between patients with atypical symptoms of MDD (MDD‐A, n = 24) versus patients without atypical symptoms (MDD‐nA; n = 94) using a Cox regression analysis. Results: A total of 62.5% of patients with MDD‐A and 36.2% of patients with MDD‐nA responded to LA. Analysis adjusted for age, sex, sufficient lithium serum concentration, and symptom severity at baseline showed a significantly higher probability of patients with atypical symptoms to respond to LA (HR 2.20, p = 0.02). Conclusion: This is the first study investigating lithium‐response in patients with MDD‐A. The MDD‐A subtype may help to predict response to LA. Trial Registration: EudraCT number: 2008‐004182‐26; ClinicalTrials.gov identifier: DRKS00026205
- 17 July 2026
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 154 (5) , 376-383
Open AccessPatients With Atypical Symptoms of Depression Respond Better to Lithium Augmentation Than Patients Without Atypical Symptoms
Introduction: Understanding the differences in treatment response between subtypes of major depressive disorder (MDD) may help to prevent lengthy trial‐and‐error processes by identifying effective treatment options. The aim of the study was to investigate the impact of atypical features of MDD (MDD‐A) on the response to lithium augmentation (LA). Methods: In a multicenter prospective cohort study, response to LA was compared between patients with atypical symptoms of MDD (MDD‐A, n = 24) versus patients without atypical symptoms (MDD‐nA; n = 94) using a Cox regression analysis. Results: A total of 62.5% of patients with MDD‐A and 36.2% of patients with MDD‐nA responded to LA. Analysis adjusted for age, sex, sufficient lithium serum concentration, and symptom severity at baseline showed a significantly higher probability of patients with atypical symptoms to respond to LA (HR 2.20, p = 0.02). Conclusion: This is the first study investigating lithium‐response in patients with MDD‐A. The MDD‐A subtype may help to predict response to LA. Trial Registration: EudraCT number: 2008‐004182‐26; ClinicalTrials.gov identifier: DRKS00026205
- 1 October 2025
- Published by Springer Nature
- p. 1-42
Meta-Analysis in Epidemiology
- Open Access
- 8 July 2025
- Published by Springer Nature in Infection
- Vol. 53 (6) , 2533-2542
Transitional care after hospitalization for sepsis in Germany– results from the population-based AVENIR cohort study
Purpose: Sepsis survivorship is associated with significant long-term morbidity, mortality and health care utilization. Transitional care between inpatient and follow-up care is crucial, but insufficiently understood. We investigated health care utilization in sepsis survivors 90 days post-discharge, comparing translational care during 2016–2019 vs. 2020 in the first year of the pandemic. Methods: This retrospective cohort study used nationwide health claims data of the “AOK– die Gesundheitskasse”. Sepsis patients with inpatient treatment in 2016–2019 were identified using explicit ICD-10 codes for sepsis and codes for organ dysfunction. A second sepsis patient cohort was identified in 2020, which included also explicitly defined sepsis patients as well as patients with COVID-19 and Influenza with evidence of organ dysfunction. Among survivors, health care utilization in the 90 days post-discharge was assessed and first health service provider contacts were visualized using Sankey diagrams. Results: Among 234,874 sepsis survivors in 2016–2019, 94.4% were treated by a general practitioner, 47.7% had ≥ 1 hospital readmission and 42.8% of patients had ≥ 1 emergency treatment 90 days post-sepsis. Nearly all patients had prompt health service provider contacts in that time frame, with physicians in the outpatient sector being the most common first and second health service provider contacts. In the 2020 cohort ( n = 69,432 survivors), more patients died without follow-up contact. Additionally, the latency to the first and second health service provider contacts were elevated compared to 2016–2019. Discussion: Sepsis survivors receive early, high-frequency follow-up care in the inpatient and outpatient sector. This may be an opportunity to implement early screening for sequelae and targeted therapies.
- 8 July 2025
- Published by Springer Nature in Infection
- Vol. 53 (6) , 2533-2542
Open AccessTransitional care after hospitalization for sepsis in Germany– results from the population-based AVENIR cohort study
Purpose: Sepsis survivorship is associated with significant long-term morbidity, mortality and health care utilization. Transitional care between inpatient and follow-up care is crucial, but insufficiently understood. We investigated health care utilization in sepsis survivors 90 days post-discharge, comparing translational care during 2016–2019 vs. 2020 in the first year of the pandemic. Methods: This retrospective cohort study used nationwide health claims data of the “AOK– die Gesundheitskasse”. Sepsis patients with inpatient treatment in 2016–2019 were identified using explicit ICD-10 codes for sepsis and codes for organ dysfunction. A second sepsis patient cohort was identified in 2020, which included also explicitly defined sepsis patients as well as patients with COVID-19 and Influenza with evidence of organ dysfunction. Among survivors, health care utilization in the 90 days post-discharge was assessed and first health service provider contacts were visualized using Sankey diagrams. Results: Among 234,874 sepsis survivors in 2016–2019, 94.4% were treated by a general practitioner, 47.7% had ≥ 1 hospital readmission and 42.8% of patients had ≥ 1 emergency treatment 90 days post-sepsis. Nearly all patients had prompt health service provider contacts in that time frame, with physicians in the outpatient sector being the most common first and second health service provider contacts. In the 2020 cohort ( n = 69,432 survivors), more patients died without follow-up contact. Additionally, the latency to the first and second health service provider contacts were elevated compared to 2016–2019. Discussion: Sepsis survivors receive early, high-frequency follow-up care in the inpatient and outpatient sector. This may be an opportunity to implement early screening for sequelae and targeted therapies.
- Open Access
- 13 December 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 153, 105520
Cost-effectiveness-analysis of oral health remotivation and reinstruction in nursing homes in a cluster-randomized controlled trial
- 13 December 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 153, 105520
Open AccessCost-effectiveness-analysis of oral health remotivation and reinstruction in nursing homes in a cluster-randomized controlled trial
- Open Access
Validation of Nutritional Approaches to Modulate Cardiovascular and Diabetic Risk Factors in Patients with Hypertriglyceridemia or Prediabetes—The MoKaRi II Randomized Controlled Study
Hypertriglyceridemia and diabetes mellitus type 2 are among the most important metabolic diseases globally. Diet plays a vital role in the development and progression of both clinical pictures. For the 10-week randomized, controlled, intervention study, 67 subjects with elevated plasma triglyceride (TG) concentrations (≥1.7 mmol/L) and 69 subjects with elevated fasting glucose concentrations (≥5.6 < 7.0 mmol/L) were recruited. The intervention groups received specially developed, individualized menu plans and regular counseling sessions to lower (A) TG or (B) fasting glucose and glycated hemoglobin A1c as well as other cardiovascular and diabetic risk factors. The hypertriglyceridemia intervention group was further supplemented with fish oil (3.5 g/d eicosapentaenoic acid + docosahexaenoic acid). The two control groups maintained a typical Western diet. Blood samples were taken every 2 weeks, and anthropometric data were collected. A follow-up examination was conducted after another 10 weeks. In both intervention groups, there were comparable significant reductions in blood lipids, glucose metabolism, and anthropometric parameters. These results were, with a few exceptions, significantly more pronounced in the intervention groups than in the corresponding control groups (comparison of percentage change from baseline). In particular, body weight was reduced by 7.4% (6.4 kg) and 7.5% (5.9 kg), low-density lipoprotein cholesterol concentrations by 19.8% (0.8 mmol/L) and 13.0% (0.5 mmol/L), TG concentrations by 18.2% (0.3 mmol/L) and 13.0% (0.2 mmol/L), and homeostatic model assessment for insulin resistance by 31.8% (1.1) and 26.4% (0.9) (p < 0.05) in the hypertriglyceridemia and prediabetes intervention groups, respectively. Some of these changes were maintained until follow-up. In patients with elevated TG or fasting glucose, implementing individualized menu plans in combination with regular counseling sessions over 10 weeks led to a significant improvement in cardiovascular and diabetic risk factors.
Open AccessValidation of Nutritional Approaches to Modulate Cardiovascular and Diabetic Risk Factors in Patients with Hypertriglyceridemia or Prediabetes—The MoKaRi II Randomized Controlled Study
Hypertriglyceridemia and diabetes mellitus type 2 are among the most important metabolic diseases globally. Diet plays a vital role in the development and progression of both clinical pictures. For the 10-week randomized, controlled, intervention study, 67 subjects with elevated plasma triglyceride (TG) concentrations (≥1.7 mmol/L) and 69 subjects with elevated fasting glucose concentrations (≥5.6 < 7.0 mmol/L) were recruited. The intervention groups received specially developed, individualized menu plans and regular counseling sessions to lower (A) TG or (B) fasting glucose and glycated hemoglobin A1c as well as other cardiovascular and diabetic risk factors. The hypertriglyceridemia intervention group was further supplemented with fish oil (3.5 g/d eicosapentaenoic acid + docosahexaenoic acid). The two control groups maintained a typical Western diet. Blood samples were taken every 2 weeks, and anthropometric data were collected. A follow-up examination was conducted after another 10 weeks. In both intervention groups, there were comparable significant reductions in blood lipids, glucose metabolism, and anthropometric parameters. These results were, with a few exceptions, significantly more pronounced in the intervention groups than in the corresponding control groups (comparison of percentage change from baseline). In particular, body weight was reduced by 7.4% (6.4 kg) and 7.5% (5.9 kg), low-density lipoprotein cholesterol concentrations by 19.8% (0.8 mmol/L) and 13.0% (0.5 mmol/L), TG concentrations by 18.2% (0.3 mmol/L) and 13.0% (0.2 mmol/L), and homeostatic model assessment for insulin resistance by 31.8% (1.1) and 26.4% (0.9) (p < 0.05) in the hypertriglyceridemia and prediabetes intervention groups, respectively. Some of these changes were maintained until follow-up. In patients with elevated TG or fasting glucose, implementing individualized menu plans in combination with regular counseling sessions over 10 weeks led to a significant improvement in cardiovascular and diabetic risk factors.
- Open Access
- 1 January 2024
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 17 (1) , e010813
Metabolic Profiling Identifies 1-MetHis and 3-IPA as Potential Diagnostic Biomarkers for Patients With Acute and Chronic Heart Failure With Reduced Ejection Fraction
BACKGROUND: Metabolomics has become a valuable tool for identifying potential new biomarkers and metabolic profiles. It has the potential to improve the diagnosis and prognosis of different phenotypes of heart failure. To generate a distinctive metabolic profile, we assessed and compared the metabolic phenotypes of patients with acute decompensated heart failure (ADHF), patients with chronic heart failure (CHF), and healthy controls. METHODS: Plasma metabolites were analyzed by liquid-chromatography mass spectrometry/mass spectrometry and the MxP Quant 500 kit in 15 patients with ADHF, 50 patients with CHF (25 with dilated cardiomyopathy, 25 with ischemic cardiomyopathy), and 13 controls. RESULTS: Of all metabolites identified to be significantly altered, 3-indolepropionic acid and 1-methyl histidine showed the highest concentration differences in ADHF and CHF compared with control. Area under the curve–receiver operating characteristic analysis showed an area under the curve ≥0.8 for 3-indolepropionic acid and 1-methyl histidine, displaying good discrimination capabilities between control and patient cohorts. Additionally, symmetrical dimethylarginine (mean, 1.97±0.61 [SD]; P =0.01) was identified as a suitable biomarker candidate for ADHF and kynurenine (mean, 1.69±0.39 [SD]; P =0.009) for CHF when compared with control, both demonstrating an area under the curve ≥0.85. CONCLUSIONS: Our study provides novel insights into the metabolic differences between ADHF and CHF and healthy controls. We here identify new metabolites for potential diagnostic and prognostic purposes.
- 1 January 2024
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 17 (1) , e010813
Open AccessMetabolic Profiling Identifies 1-MetHis and 3-IPA as Potential Diagnostic Biomarkers for Patients With Acute and Chronic Heart Failure With Reduced Ejection Fraction
BACKGROUND: Metabolomics has become a valuable tool for identifying potential new biomarkers and metabolic profiles. It has the potential to improve the diagnosis and prognosis of different phenotypes of heart failure. To generate a distinctive metabolic profile, we assessed and compared the metabolic phenotypes of patients with acute decompensated heart failure (ADHF), patients with chronic heart failure (CHF), and healthy controls. METHODS: Plasma metabolites were analyzed by liquid-chromatography mass spectrometry/mass spectrometry and the MxP Quant 500 kit in 15 patients with ADHF, 50 patients with CHF (25 with dilated cardiomyopathy, 25 with ischemic cardiomyopathy), and 13 controls. RESULTS: Of all metabolites identified to be significantly altered, 3-indolepropionic acid and 1-methyl histidine showed the highest concentration differences in ADHF and CHF compared with control. Area under the curve–receiver operating characteristic analysis showed an area under the curve ≥0.8 for 3-indolepropionic acid and 1-methyl histidine, displaying good discrimination capabilities between control and patient cohorts. Additionally, symmetrical dimethylarginine (mean, 1.97±0.61 [SD]; P =0.01) was identified as a suitable biomarker candidate for ADHF and kynurenine (mean, 1.69±0.39 [SD]; P =0.009) for CHF when compared with control, both demonstrating an area under the curve ≥0.85. CONCLUSIONS: Our study provides novel insights into the metabolic differences between ADHF and CHF and healthy controls. We here identify new metabolites for potential diagnostic and prognostic purposes.